Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
April 7th, 2023
This article describes a detailed protocol to increase glucose concentration in the cerebrospinal fluid (CSF) of mice. This approach can be useful for studying the effects of high CSF glucose on neurodegeneration, cognition, and peripheral glucose metabolism in mice.
This technique increases the Cerebrospinal Fluid or CSF glucose levels in mice without affecting their blood glucose concentration. This helps to investigate the direct effects of high CSF glucose levels on the animal's brain function. This technique can establish animal models to explore the theological role of higher CSF glucose on cognitive dysfunction.
Leading to the discovery of new molecular targets to improve cognitive function. The method will also help determine whether high CSF glucose levels are sufficient to mediate phenotypes of neurodegenerative disorders in mice. Attention must be paid to the proper assembly and priming of the cannula setup and insertion of the cannula in the brain at the correct coordinates.
To begin the surgery for Osmotic Minipump Implantation place the anesthetized mouse on the stereotaxic frame. Fit the animal's head on the incisor bar. Cover the nose with the nose cone to maintain the anesthesia and connect isofluorane flow to the nose cone at a rate of 1.5 to 2%Place a heating pad under the mouse to maintain the body temperature.
After disinfecting the surgical area and making an incision expose the skull surface with a spatula and wipe the blood, if any, with cotton tips. Use a cauterizer if bleeding profusely. Rub with a cotton tip dipped in 3%hydrogen peroxide to expose the cranial sutures.
Working under a microscope, take note of bregma and lambda to navigate the skull coordinates. Set all the coordinates to zero at bregma. Using an electric drill carefully and without rupturing the dura mater make a hole at the coordinates 0.5 millimeters posterior to bregma and 1 millimeter lateral to midline toward the right.
Insert a hemostat and gently open and close it to make a pocket for the mini pump. Holding the pump from the tip of the flow modulator push it through the incised skin into the created pocket. Apply some glue on the underside of the cannula, and fix it in the cannula holder.
Ensure that the cannula is not clogged and the solution is flowing properly. Then lower the cannula slowly through the drilled hole, two millimeters ventral to the skull surface. Leave it there for at least five minutes to allow the glue to solidify.
With the help of scissors, clip the top of the cannula ensuring it doesn't dislodge from the skull surface. Cover the cannula with a layer of dental cement for extra support. For Cerebrospinal Fluid or CSF collection, place the properly anesthetized mouse on the stereotaxic frame.
After fixing the head on the frame as demonstrated previously rotate the knobs to tilt the head so that the nose faces downward. After disinfecting the surgical area and making an incision remove the support from the mouse body and let the mouse rest vertically so that the neck is fully extended dorsally. Using curved blunt forceps, gently bisect the posterior neck muscles from the midline to create a small window.
Then use a wet cotton tip applicator to gently displace the neck muscles from the midline to the periphery. Observe whether the cisterna magna is exposed as a triangular window with a transparent dura membrane. Place the micro manipulator assembly on the stereotaxic frame next to the mouse while ensuring the capillary tip does not touch any surface.
Gently break the capillary tip without disturbing the setup. Rotate the corresponding knobs on the micro manipulator to align slowly and move the capillary tip toward the cisterna magna. Some resistance is felt once the capillary tip touches the cisterna magna membrane.
Very slowly push the tip against the membrane with the help of the knobs being careful not to damage any blood vessels in the membrane. As the membrane is pierced, CSF flows into the capillary at once due to negative capillary pressure. Leave the setup for a few minutes until approximately 10 microliters of CSF collects in the capillary.
Carefully remove the capillary from the syringe and attach it to a microcap bulb dispenser. Press the bulb to transfer the CSF into a sterile micro centrifuge tube. Place the support under the mouse and rotate the stereotaxic knobs to level the head.
Close the wound with nylon sutures. Inject 300 microliters of sterile saline subcutaneously before removing the mouse from the apparatus. Give postoperative care to the animals until it is time to remove the sutures, about 7 to 10 days after surgery.
CSF collected 10 days after the surgery showed about a sixfold increase in glucose level in mice, infused with 50%glucose compared to that in mice infused with CSF. However, the blood glucose levels were not different between the groups. While lowering the cannula in the brain, retract it back and check if CSF comes out of the hole.
It is also vital to correctly identify cisterna magna and prevent contamination of CSF with blood. This technique can also be used to deliver any drug that is unable to cross the blood-brain barrier to test its effect on brain function. There is a very limited number of animal models of diabetes, and they disturb glucose homeostasis in the peripheral environment.
This model, however, helps investigate brain specific changes in glucose regulation on the neural function.
View the full transcript and gain access to thousands of scientific videos
Overview
This article outlines a surgical protocol to elevate glucose levels in the cerebrospinal fluid (CSF) of mice without altering blood glucose concentrations. This technique is pivotal for examining the implications of elevated CSF glucose on neurodegeneration, cognitive functions, and peripheral glucose metabolism in murine models.
Key Study Components
Research Area
- Neurodegeneration
- Cognition and brain function
- Metabolic regulation
Background
- High glucose in CSF could have direct effects on brain functionality.
- Understanding these effects is crucial for developing models of cognitive impairment and neurodegenerative diseases.
- Few models exist that accurately reflect brain-specific glucose regulation in diabetes.
Methods Used
- Stereotaxic surgery for osmotic mini-pump implantation to modify CSF glucose levels.
- Mice used as the main biological model.
- Micro-manipulation techniques for CSF collection.
Main Results
- Successful elevation of CSF glucose levels post-surgery without affecting blood glucose.
- Significant increase in glucose concentration found in CSF collected after 10 days.
- Clarification of the role of CSF glucose in neurodegenerative disorders.
Conclusions
- The study establishes a method for investigating the specific effects of glucose levels in the CSF on brain function.
- This could lead to identifying new molecular targets for improving cognitive functions impaired by neurodegeneration.
Frequently Asked Questions
Executive Industry Relevance
Directly elevating cerebrospinal fluid (CSF) glucose in mice enables precise interrogation of central glucose effects on neural function, independent of peripheral glucose changes. This model addresses a critical gap in understanding the mechanistic link between diabetes, cognitive decline, and neurodegeneration. The approach supports target validation and de-risking for CNS-focused metabolic and neurodegenerative disease portfolios.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables direct testing of the causal role of high CSF glucose in cognitive dysfunction and neurodegeneration.
- Supports mechanistic de-risking by isolating central from peripheral glucose effects.
- Facilitates identification of brain-specific molecular targets for cognitive impairment.
Screening & Assay Development
- Provides a validated in vivo system for evaluating CNS-targeted interventions under controlled CSF glucose conditions.
- Enables reproducible measurement of CSF glucose and associated phenotypes for quantitative assay development.
- Supports downstream compound screening for agents unable to cross the blood-brain barrier.
Translational & Preclinical Research
- Aligns with disease-relevant models for Alzheimer’s and diabetes-associated neurodegeneration.
- Enables translational biomarker exploration by linking CSF glucose to cognitive and neural outcomes.
- Supports risk-adjusted advancement of CNS metabolic targets into preclinical pipelines.
Pipeline & Workflow Integration
This method integrates at the interface of early discovery and preclinical validation, enabling hypothesis-driven studies of central glucose regulation and its impact on neural pathways.
- Discovery Biology: Supports hypothesis testing on the sufficiency of CSF glucose elevation to induce CNS phenotypes.
- Screening: Provides a reproducible in vivo platform for evaluating CNS-active compounds and interventions.
- Analytics: Delivers quantitative CSF glucose measurements and phenotypic readouts for comparative analysis.
- Translational Research: Bridges discovery findings to disease-relevant preclinical models for neurodegeneration.
- Enterprise Reuse: Offers a reusable animal model for diverse CNS metabolic and neurodegenerative research programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in CNS target validation by isolating central glucose effects.
- Operational Value: Standardizes in vivo procedures for reproducible CSF manipulation and measurement.
- Strategic Value: Enables informed go/no-go decisions for CNS metabolic targets and reduces late-stage biological risk.
- Portfolio Impact: Supports risk-adjusted prioritization of CNS-focused assets in neurodegeneration and metabolic disease pipelines.
Implementation Considerations
- Requires expertise in stereotaxic surgery and precise cannula placement for reliable CSF infusion.
- Demands access to micro-manipulation instrumentation and validated analytical assays for CSF glucose quantification.
- Necessitates rigorous cross-team standardization to ensure reproducibility and minimize contamination.
- Adaptation to other CNS-active agents or disease models may require protocol optimization.
- Careful attention to surgical and post-operative care is essential to maintain animal welfare and data integrity.
